Article
Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer.
Journal of medical genetics - 1 Jan 2022
Moreno-Cabrera José Marcos, Del Valle Jesús, Feliubadaló Lidia, Pineda Marta, González Sara, Campos Olga, Cuesta Raquel, Brunet Joan, Serra Eduard, Capellà Gabriel, Gel Bernat, Lázaro Conxi
Abstract excerpt
INTRODUCTION: Germline CNVs are important contributors to hereditary cancer. In genetic diagnostics, multiplex ligation-dependent probe amplification (MLPA) is commonly used to identify them. However, MLPA is time-consuming and expensive if applied to many genes, hence many routine laboratories test only a subset of genes of interest. METHODS AND RESULTS: We evaluated a next-generation sequencing (NGS)-based CNV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
